Brand
Johnson & Johnson Orthopaedics
The orthopaedics portfolio covers joint reconstruction, trauma, spine, and sports-related injuries. Johnson & Johnson's fiscal 2025 Form 10-K still includes it in MedTech and says a separation was announced in October 2025. The filing does not use a separate company name for that portfolio.
Also searched as J&J Orthopaedics.
Documented stakes
The fiscal 2025 Form 10-K describes the Orthopaedics portfolio as part of MedTech. In October 2025 the company announced an intention to separate the business, with a targeted completion 18 to 24 months after the announcement. The separation was not completed in this report, so the portfolio is still a current Johnson & Johnson business.
As of Dec 28, 2025. Last checked Sep 22, 2026.
- Johnson & Johnson Form 10-K for the fiscal year ended December 28, 2025 · U.S. Securities and Exchange Commission